Predicting Progression of Developing Myeloma in a High Risk-Screened Population (PROMISE)

  • STATUS
    Recruiting
Send
Updated on 19 February 2024

Summary

Normal 0 false false false EN-US X-NONE X-NONE Normal 0 false false false EN-US X-NONE X-NONE

Normal 0 false false false EN-US X-NONE X-NONE
The PROMISE study is the first study to test healthy people who may be at risk for early warnings signs of a blood cancer called multiple myeloma. 

Normal 0 false false false EN-US X-NONE X-NONE Multiple myeloma is a type of blood cancer that occurs in the bone marrow.  Before a person develops multiple myeloma, their marrow begins to make abnormal cells and proteins, which can be an early warning sign of the disease.

We're inviting qualifying adults with higher risks for multiple myeloma to participate in a screening study for early warning signs of the disease.
Normal 0 false false false EN-US X-NONE X-NONE
Normal 0 false false false EN-US X-NONE X-NONE
We will further study people who test positive for these early warning signs of multiple myeloma so that we can learn how to prevent them from developing into cancer. 
 
Your participation may help researchers find new ways to prevent and treat blood cancer.
 

Description

Normal 0 false false false EN-US X-NONE X-NONE
Normal 0 false false false EN-US X-NONE X-NONE Normal 0 false false false EN-US X-NONE X-NONE Normal 0 false false false EN-US X-NONE X-NONE
Normal 0 false false false EN-US X-NONE X-NONE Normal 0 false false false EN-US X-NONE X-NONE Normal 0 false false false EN-US X-NONE X-NONE Normal 0 false false false EN-US X-NONE X-NONE Normal 0 false false false EN-US X-NONE X-NONE
Normal 0 false false false EN-US X-NONE X-NONE How To Join and Get Screened for Free:
 
1.     Take a short survey and decide whether to go to the next step.
 
2.     Once you have completed the enrollment and are qualified for a free screening, we will send a collection kit to you at no cost.
 
3.     When the kit arrives, it will contain instructions for how to schedule your free screening at a Quest Diagnostics lab near you where they will collect a small amount of blood. 
 
4.     We will check your blood sample for certain proteins that we call “precursor conditions for multiple myeloma.
 
5.     We will notify all participants of their results. 
 
Normal 0 false false false EN-US X-NONE X-NONE
 
Please take our survey to see if you qualify: PROMISE Eligibility Questionnaire 
 
 
Normal 0 false false false EN-US X-NONE X-NONE
Normal 0 false false false EN-US X-NONE X-NONE
This study aims to find new ways to prevent and treat blood cancer.

Your participation may help prevent multiple myeloma in future generations.

For more information, please visit the PROMISE study website: https://www.enroll.promisestudy.org/

FAQ

Normal 0 false false false EN-US X-NONE X-NONE
Normal 0 false false false EN-US X-NONE X-NONE
This study aims to find new ways to prevent and treat blood cancer.

Your participation may help prevent multiple myeloma in future generations.

For more information, please visit the PROMISE study website: https://www.enroll.promisestudy.org/

Details
Condition healthy,cancer,multiple mylemoa,myeloma,MGUS,cancer screening,smoldering multiple myeloma,monoclonal gammopathy of undetermined significance,waldentrom macroglobulinemia
Age 40years - 75years
Clinical Study IdentifierTX11138
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.